Healthcare provider profile · identity verified

Brunel Bredy, MD

Family Practice · KING CITY, CA · NPI 1407925860

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	561	219
Amlodipine Besylate	Amlodipine Besylate	412	155
Losartan Potassium	Losartan Potassium	290	111
Fluticasone Propionate	Fluticasone Propionate	224	87
Albuterol Sulfate Hfa	Albuterol Sulfate	218	103
Lisinopril	Lisinopril	215	83
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	203	74
Levothyroxine Sodium	Levothyroxine Sodium	193	58
Famotidine	Famotidine	146	62
Tamsulosin Hcl	Tamsulosin Hcl	134	53
Omeprazole	Omeprazole	133	54
Gabapentin	Gabapentin	132	44
Simvastatin	Simvastatin	130	41
Metformin Hcl Er	Metformin Hcl	126	45
Alendronate Sodium	Alendronate Sodium	118	44
Ibuprofen	Ibuprofen	117	50
Trazodone Hcl	Trazodone Hcl	112	43
Pantoprazole Sodium	Pantoprazole Sodium	103	31
Chlorthalidone	Chlorthalidone	102	35
Furosemide	Furosemide	100	41
Hydrochlorothiazide	Hydrochlorothiazide	100	37
Duloxetine Hcl	Duloxetine Hcl	97	36
Metformin Hcl	Metformin Hcl	96	32
Metoprolol Tartrate	Metoprolol Tartrate	96	44
Prednisone	Prednisone	90	75
Breyna	Budesonide/Formoterol Fumarate	86	35
Potassium Chloride	Potassium Chloride	84	28
Hydrocortisone	Hydrocortisone	75	35
Atenolol	Atenolol	73	28
Doxycycline Monohydrate	Doxycycline Monohydrate	73	65
Metoprolol Succinate	Metoprolol Succinate	73	25
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	69	23
Allopurinol	Allopurinol	68	29
Ozempic	Semaglutide	67	14
Spiriva Respimat	Tiotropium Bromide	61	19
Tramadol Hcl	Tramadol Hcl	61	25
Glipizide	Glipizide	60	28
Jardiance	Empagliflozin	59	22
Meloxicam	Meloxicam	58	43
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	54	24
Spironolactone	Spironolactone	53	20
Rosuvastatin Calcium	Rosuvastatin Calcium	51	17
Pravastatin Sodium	Pravastatin Sodium	49	19
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	49	20
Carvedilol	Carvedilol	48	20
Betamethasone Valerate	Betamethasone Valerate	47	27
Valsartan	Valsartan	45	17
Cephalexin	Cephalexin	44	42
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	44	40
Olanzapine	Olanzapine	44	suppressed
Colchicine	Colchicine	43	18
Terazosin Hcl	Terazosin Hcl	43	13
Alvesco	Ciclesonide	42	24
Ondansetron Hcl	Ondansetron Hcl	42	21
Zolpidem Tartrate	Zolpidem Tartrate	38	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	37	14
Pradaxa	Dabigatran Etexilate Mesylate	37	16
Finasteride	Finasteride	36	14
Baclofen	Baclofen	35	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	34	12
Humulin N	Insulin Nph Human Isophane	32	13
Hydroxyzine Hcl	Hydroxyzine Hcl	32	13
Lactulose	Lactulose	32	suppressed
Pregabalin	Pregabalin	32	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	31	14
Paxlovid	Nirmatrelvir/Ritonavir	31	31
Fluocinonide	Fluocinonide	30	12
Fluoxetine Hcl	Fluoxetine Hcl	30	12
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Clopidogrel	Clopidogrel Bisulfate	29	11
Hydralazine Hcl	Hydralazine Hcl	29	12
Montelukast Sodium	Montelukast Sodium	29	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	29	suppressed
Azelastine Hcl	Azelastine Hcl	28	12
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	27	27
Wixela Inhub	Fluticasone Propion/Salmeterol	27	11
Acyclovir	Acyclovir	26	11
Sumatriptan Succinate	Sumatriptan Succinate	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	18
Escitalopram Oxalate	Escitalopram Oxalate	23	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	23	12
Sertraline Hcl	Sertraline Hcl	23	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	suppressed
Clobetasol Propionate	Clobetasol Propionate	22	suppressed
Clonazepam	Clonazepam	22	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	20
Glipizide Er	Glipizide	21	suppressed
Naproxen	Naproxen	21	13
Oxycodone Hcl	Oxycodone Hcl	21	13
Digoxin	Digoxin	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Fenofibrate	Fenofibrate	19	suppressed
Lorazepam	Lorazepam	19	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Lidocaine	Lidocaine	18	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Sucralfate	Sucralfate	18	suppressed
Citalopram Hbr	Citalopram Hydrobromide	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Glimepiride	Glimepiride	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	15	suppressed
Metronidazole	Metronidazole	15	suppressed
Nabumetone	Nabumetone	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Topiramate	Topiramate	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Enbrel Sureclick	Etanercept	14	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	12
Bisoprolol Fumarate	Bisoprolol Fumarate	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Lidocaine Hcl Viscous	Lidocaine Hcl	13	12
Temazepam	Temazepam	13	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Naltrexone Hcl	Naltrexone Hcl	12	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	11	suppressed
Diazepam	Diazepam	11	suppressed
Eliquis	Apixaban	11	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	11	suppressed
Varenicline Tartrate	Varenicline Tartrate	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error